In line with these findings, LUCAT1 and CASC9 silencing in HCC cells, was associated with a reduction of CDH2 in both PLC/PRF5 and SNU449 cells (Figure 5I and 5J). This evidence concerns the gene CASC9 and hepatocellular carcinoma.